Galectin Therapeutics Company
Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.
Technology:
Biologics
Industry:
PharmTech
Headquarters:
Norcross, Georgia, United States
Founded Date:
2000
Employees Number:
11-50
Funding Status:
IPO
Estimated Revenue:
Less than $1M
Register and Claim Ownership